Brachytherapy device having seed tubes with individually-settable tissue spacings

- Portola Medical, Inc.

A brachytherapy device may include a plurality of rods, each configured to move between a straightened position and a bowed position, the plurality of rods configured to collectively form a shaft while each rod is in the straightened position and to collectively form at least one cage while at least some of the rods are in the bowed position, at least some of the rods having lumens that are configured to receive and hold radioactive material. A brachytherapy device may further include a rotatable mechanism configured to cause at least some of the plurality of rods to move between the straightened position and the bowed position upon rotation of the rotatable mechanism.

Skip to: Description  ·  Claims  ·  References Cited  · Patent History  ·  Patent History
Description
CROSS-REFERENCE TO RELATED APPLICATIONS

This application claims priority to U.S. Provisional Patent Application Ser. No. 60/864,288, entitled “Brachytherapy Device Having Seed Tubes With Individually-Settable Tissue Spacing,” filed Nov. 3, 2006. This application is also related to U.S. patent application Ser. No. 11/305,437, entitled “Brachytherapy Apparatus,” filed Dec. 16, 2005, and U.S. Continuation application Ser. No. 11/379,739, entitled “Brachytherapy Apparatus for Asymmetrical Cavities,” filed Apr. 21, 2006 now abandoned. The contents of all of these applications are incorporated herein by reference in their entirety.

BACKGROUND

1. Field

This application relates to brachytherapy.

2. Description of Related Art

Brachytherapy is used in a variety of treatments. Often times, a high dose of radiation is needed. However, it may be difficult to apply a high dose to areas in need of treatment, without also causing damage to healthy tissue in the vicinity.

SUMMARY

A brachytherapy device may include a plurality of rods, each configured to move between a straightened position and a bowed position, the plurality of rods configured to collectively form a shaft while each rod is in the straightened position and to collectively form at least one cage while at least some of the rods are in the bowed position, at least some of the rods having lumens that are configured to receive and hold radioactive material. A brachytherapy device may further include a rotatable mechanism configured to cause at least some of the plurality of rods to move between the straightened position and the bowed position upon rotation of the rotatable mechanism.

A brachytherapy device may comprise a plurality of rods, each configured to move between a straightened position and a bowed position, the plurality of rods configured to collectively form a shaft while each rod is in the straightened position and to collectively form at least one cage while at least some of the rods are in the bowed position, at least some of the rods having lumens that are configured to receive and hold radioactive material, wherein some of the rods are configured to form a first cylinder while in the straightened position and the other rods are configured to form a second cylinder while in the straightened position that surrounds the first cylinder, whereby the plurality of rods are further configured such that at least a substantial portion of each the rod in the second cylinder lies between two rods within the first cylinder while in the straightened position.

A brachytherapy device may further comprise a plurality of rods, each configured to move between a straightened position and a bowed position, the plurality of rods configured to collectively form a shaft while each rod is in the straightened position and to collectively form at least one cage while at least some of the rods are in the bowed position, at least some of the rods having lumens that are configured to receive and hold radioactive material, wherein each rod has opposing longitudinal edges, each of which is configured to interlock with a longitudinal edge of a neighboring rod while in the straightened position.

A brachytherapy device may include a first and a second set of rods, at least some of the rods having lumens that are configured to receive and hold radioactive material. A brachytherapy device may further include a group expansion mechanism associated with the first set of rods and configure to collectively move the first set of rods in unison, each between a straightened position and a bowed position, the first set of rods configured to collectively form a shaft while each of the first set of rods is in the straightened position and to collectively form a cage while each of the first set of rods is in the bowed position. A brachytherapy device may further include a rod bowing mechanism associated with each of the second set of rods and configured to individually move each of the second set of rods between a straightened and a bowed position, the second set of rods configured to collectively form a shaft while each of the second set of rods is in the straightened position.

A brachytherapy device may include a plurality of rods configured to move between a straightened position and a bowed position, the rods configured to collectively form a shaft while each of the second set of rods is in the straightened position, at least some of the rods having lumens configured to receive and hold radioactive material. A brachytherapy device may further include a plurality of actuators, each associate with one of the rods and configured to cause the rod with which it is associated to move from the straightened position to the bowed position in incremental steps, each of the incremental steps being delineated by a ratchet mechanism.

These, as well as other components, steps, features, objects, benefits, and advantages, will now become clear from a review of the following detailed description of illustrative embodiments and the accompanying drawings.

BRIEF DESCRIPTION OF DRAWINGS

The drawings disclose illustrative embodiments. They do not set forth all embodiments. Other embodiments may be used in addition or instead. Details that may be apparent or that are unnecessary are also often omitted to save space or for more effective illustration. When the same numeral appears in different drawings, it is intended to refer to the same or like components or steps.

FIG. 1 illustrates a pre-expander balloon apparatus.

FIG. 2 illustrates the pre-expander balloon apparatus inserted into a cavity of a breast and inflated.

FIG. 3 illustrates a sleeve having a flanged end.

FIG. 4 illustrates the sleeve being cut by a cutting tool.

FIG. 5 illustrates a trocar being inserted into the sleeve.

FIG. 6 illustrates the trocar after it has been inserted through the sleeve.

FIG. 7 illustrates the trocar and sleeve after they have been inserted into the resected cavity of the breast.

FIG. 8 illustrates the sleeve inserted into the breast after the trocar has been removed.

FIG. 9 illustrates a tube apparatus being inserted into a distal end of the sleeve.

FIG. 10 is an enlarged view of the tube apparatus.

FIG. 11 illustrates the tube apparatus with its outer tubes partially expanded.

FIG. 12 illustrates the tube apparatus with the outer tubes more fully expanded.

FIG. 13 illustrates the tube apparatus with the outer tubes expanded within the cavity in the breast.

FIG. 14(a) illustrates the tube apparatus with the outer tubes expanded and with a set of inner tubes individually expanded within the cavity in the breast.

FIG. 14(b) is an enlarged perspective view of the proximate end of the tube apparatus.

FIG. 14(c) is an enlarged perspective view of the distal end of tubes in the tube apparatus.

FIG. 14(d) illustrates an end view of the expanded inner and outer tubes.

FIG. 15 illustrates a cross-section of a handle of the tube apparatus.

FIG. 16 illustrates a perspective view of the cross-section of the handle.

FIG. 17 illustrates an enlarged perspective view of the cross-section of the handle.

FIG. 18 illustrates a hemostat being used to lock the tubes in their expanded positions.

FIG. 19 illustrates the handle being cut from the tubes by a cutting tool.

FIG. 20 illustrates the tubes while locked and after being separated from the handle.

FIG. 21 illustrates an adapter being positioned for attachment to the sleeve.

FIG. 22 illustrates the adapter attached to the sleeve.

FIG. 23 illustrates a cap attached to the distal end of the sleeve.

FIG. 24 illustrates a hemostat being used to unlock the tubes.

FIG. 25 illustrates the hemostat being used to straighten the tubes.

FIG. 26 illustrates the hemostat being used to grab the tubes after they have been straightened.

FIG. 27 illustrates the straightened tubes being removed from the sleeve by the hemostat.

FIG. 28 illustrates the sleeve being removed from the breast.

 DETAILED DESCRIPTION OF ILLUSTRATIVE EMBODIMENTS

Illustrative embodiments are now discussed. Other embodiments may be used in addition or instead. Details that may be apparent or that are unnecessary are also often omitted to save space or for more effective presentation.

FIG. 1 illustrates a pre-expander balloon apparatus. As shown in FIG. 1, the pre-expander balloon apparatus may include a balloon 101—illustrated in a deflated state—an inflation tube 103, and an inflation applicator 105.

The balloon 101 may be configured to inflate with gas or fluid. The inflation tube 103 may be configured to carry the gas or fluid from the inflation applicator 105 to the balloon 101. The inflation applicator 105 may include a reservoir cylinder 107 and a plunger 109 which may contain the gas or fluid. Any type of gas or fluid may be used. In one embodiment, saline may be used.

FIG. 2 illustrates the pre-expander balloon apparatus inserted into a cavity 201. The cavity 201 may be a cavity in any area of a body, such as in a breast 205. It may be a cavity formed by the extraction of a cancerous tumor or that exists for any other reason.

The balloon 101 while in its deflated state may be inserted through an opening 207 in the skin surface of the breast 205 and into the cavity 201. The opening 207 and the pathway to the cavity may have been created during the resection of the tumor or at any other time. Once in the cavity, the balloon 101 may be expanded by applying force to the plunger 109 while retaining a grasp of tabs 108 on the reservoir cylinder 107.

The balloon 101 may be inflated until it substantially fills the cavity. An X-ray or CT scan may be used to determine when this point has been reached.

The distance between the opening 207 on the skin surface and the initial entry point 209 to the cavity 201 may be measured. For this purpose, the inflation tube 103 may be marked with gradations. The gradation that is closest to the opening 207 on the inflation tube 103 may be noted and this measurement may be recorded for later use.

The inflation applicator 105 may be detached from the inflation tube 103 and the inflation tube 103 may be sealed so that the balloon 101 remains inflated. The inflated balloon 101 may be left within the cavity 201 until the patient is ready for radiation treatment.

When the patient is ready for radiation treatment, the inflation tube 103 may be reopened at its distal end, thus allowing the balloon 101 to deflate. The balloon 101 and the inflation tube 103 may then be removed from the breast 205.

FIG. 3 illustrates a sleeve 301 having a flanged end 303. Before use, the length of the sleeve 301 may be trimmed to the initial depth of the cavity 201. As explained above, this measurement may have already been made by noting the gradation on the inflation tube 103 that was at the surface of the skin. It may have been made by other means or may be made now.

FIG. 4 illustrates the sleeve 301 being cut by a cutting tool 401. The cutting tool 401 may have a cutting blade 403 and may be positioned to cut the sleeve 301 at a length that is approximately equal to the initial depth of the cavity within the breast 205.

FIG. 5 illustrates a trocar 501 being inserted into the sleeve 301.

FIG. 6 illustrates the trocar 501 after it has been inserted through the sleeve 301.

The trocar 501 and the sleeve 301 may be inserted into the cavity 201 of the breast 205, as shown in FIG. 7. The sleeve 301 may be pushed into the breast until its flanged end abuts the surface of the skin and its proximate end reaches the initial entry point 209 into the cavity.

FIG. 8 illustrates the sleeve 301 inserted into the breast 205 after the trocar 501 has been removed. The flanged end 303 of the sleeve 301 may be sutured to the breast at this time.

FIG. 9 illustrates a tube apparatus 901 being inserted into a distal end 903 of the sleeve 301. The tube apparatus 901 may continue to be inserted into the sleeve 301 until its proximate end 905 passes through the proximate end 907 of the sleeve 301 and is stopped from further free movement by the opposite end 909 of the cavity 201.

Trimming the sleeve 301 to the initial depth of the cavity 201 and inserting the tube apparatus 901 into the cavity 201 until its proximate end 905 engages the opposite end 909 of the cavity 201 may cause the tube apparatus 901 to protrude beyond the proximate end 907 of the sleeve 301 by an amount that is approximately equal to the diameter of the cavity 201 and to be approximately centered within the cavity 201. In this way, a single sized tube apparatus 901 may be used to treat cavities of varying size, as will become apparent from the discussion below.

FIG. 10 is an enlarged view of the tube apparatus 901. The tube apparatus 901 may include a set of tubes 1001 positioned within the sleeve 301 and attached to a handle 1003.

The set of tubes 1001 may include any number of tubes bundled together. The proximate ends 1005 of the tubes 1001 may be bound together using any means, such as glue or an ultrasonic bond.

The tubes 1001 may be made of any material, including material that is normally straight, but resiliently flexes after longitudinal compression. Plastic or any other type of material may be used. A central lumen may or may not be provided within one, some or all of the tubes 1001.

The tubes 1001 may be of any number. Twelve will be discussed. A different number, such as 4, 5, 6, 7, 8, 9, 10, 11, 13, 14, 15, 16, etc. may be used instead.

FIG. 11 illustrates the tube apparatus with its outer tubes 1107 partially expanded. The outer tubes 1107 constitute an outer portion of the tubes 1001.

A gear 1105 may mesh with threads 1101 on a collar 1102 that may be attached to distal ends of the outer tubes 1107. A rod 1109 may run through the center of the tubes 1001 and may be attached at its proximate end to the proximate end 1005 of the tubes 1001 and at its distal end to an end 1111 of the handle 1003. Any means may be used to effectuate this attachment, such as glue or ultrasonic bonding.

When the gear 1105 is rotated with respect to the handle 1003, this may cause the collar 1102 to move laterally away from the handle 1003 and to apply a longitudinal compressive force to the outer tubes 1107, thus causing them to expand in unison as show in FIG. 11.

FIG. 12 illustrates the tube apparatus the outer tubes 1107 more fully expanded. As shown in FIG. 12, the collar 1102 has been separated even further from the handle 1003 by continued rotation of the gear 1105 with respect to the handle 1003. This relative rotation may continue until the outer tubes 1107 substantially fill the cavity 201 in the breast 205. During some procedures, the rotation may be halted before this point is reached. During other procedures, the rotation may continue past this point.

FIG. 13 illustrates the tube apparatus with the outer tubes 1107 expanded within the cavity 201 in the breast 205. An X-ray or CT scan may be taken to verify that the outer tubes 1107 have been expanded to the desired amount and/or to provide information about adjustments that may be needed.

The number of the outer tubes 1107 may vary. Six are illustrated in FIG. 13. A different number may be used, such as 3, 4, 5, 7, or 8. The outer tubes 1107 may be oriented so that they are evenly distributed around the perimeter of the rod 1109, or they may be distributed in an uneven manner.

FIG. 14(a) illustrates the tube apparatus with the set of outer tubes 1107 expanded and with a set of inner tubes 1401 individually expanded within the cavity 20. Thumb sliders 1403 may each be separately attached to one of the inner tubes 1401. Each of the thumb sliders 1403 may be slid forward with respect to the handle 1003, causing longitudinal compression of the inner tube to which it is attached. This may cause the inner tube to bend outwardly. The amount of the bending may be a function of the degree to which the thumb slider is slid forward.

Each of the thumb sliders 1403 may include a ratchet or other type of mechanism that prevents the thumb slider from retreating, unless urged to do so by thumb pressure in the opposite direction.

Any number of inner tubes may be used for the set of inner tubes 1401. Six are illustrated in FIG. 14(a). A different number may be used, such as 1, 2, 3, 4, 5, 7, or 8.

As illustrated in FIG. 14(a), the outer tubes 1107 may surround the inner tubes 1401. In turn, the inner tubes 1107 may surround the rod 1109. These surrounding relationships may also exist when the tubes 1001 are in their uncompressed positions illustrated in FIG. 10. In another embodiment, the outer tubes 1107 and the inner tubes 1401 may all be at approximately the same radial position from the rod 1109 when in the uncompressed position shown in FIG. 10.

The outer tubes 1107 may be equal in number to the inner tubes 1401, as illustrated in FIG. 14(a). There may instead be more outer tubes than inner tubes or less.

The amount of bowing in each of the inner tubes 1401 that is caused by the sliding of its respective thumb slider may vary from procedure to procedure. The criteria that is employed for determining the amount may also vary.

During some procedures, all of the inner tubes 1401 may initially be bowed in the same amount in accordance with predetermined information, such as a formula, algorithm, or specification. This predetermined information may be dependent upon the particular patient and his or her situation. Alternately, it may be patient independent.

After initially bowing each of the inner tubes 1401 to this predetermined amount, adjustments may be made to one or more of the inner tubes 1401 to protect healthy tissue and/or to increase the dose to certain areas of the cavity 201. For example, the bowing of one or more of the inner tubes 1401 may be individually reduced by moving its respective thumb slider backwards so as to better protect healthy tissue in its vicinity, such as skin, a lung or the heart. Similarly, the bowing of one or more of the inner tubes 1401 may be individually increased by moving its respective thumb slider forwards so as to apply a greater dose to tissue in its vicinity.

FIG. 14(b) is an enlarged perspective view of the proximate end of the tube apparatus. It reveals details of the outer tubes 1107, the inner tubes 1401, the rod 1109, and the proximate end 1005.

FIG. 14(c) is an enlarged perspective view of the distal end of the tubes 1001 before they are inserted into the handle 1003. It reveals details of interlocking flanges between each of the outer tubes 1107, such as interlocking flanges 1402 and 1404, and between each of the inner tubes 1401, such as interlocking flanges 1406 and 1408. These interlocking flanges allow each of the tubes to slide separately with respect to its neighbors, while minimizing leaks. FIG. 14(c) also illustrates lumens that may run though the approximate center of each of the tubes 1001, such as lumen 1410. It also illustrates nesting between the inner tubes 1401 and the outer tubes 1107. This nesting may allows the outer tubes 1107 to slide longitudinally with respect to the inner tubes 1401.

FIG. 14(d) is an end view of the expanded inner tubes 1401 and outer tubes 1107. As illustrated in FIG. 14(d), each of the outer tubes 1107 may be bowed to the same degree and in an amount that is greater than the bowing of each of the inner tubes 1401. Although the bowing of each of the inner tubes 1401 is illustrated as being substantially the same in FIG. 14(d), there may be substantial variation among the bowing of each of the inner tubes 1401, as discussed above.

FIG. 15 illustrates a cross-section of the handle 1003.

FIG. 16 illustrates a perspective view of the cross-section of the handle 1003 shown in FIG. 15. As shown in FIG. 16, ratchet teeth 1601 may cooperate with one of the thumb sliders 1403 to lock it in position after forward movement.

FIG. 17 is an enlarged perspective view of the cross-section of the handle 1003. FIG. 17 illustrates further details, including the interlocking relationship between each of the thumb sliders 1403 and the inner tube to which it applies longitudinal compressive force.

FIG. 18 illustrates a hemostat 1801 being used to lock the tubes 1001 in their bowed positions. A locking clamp 1803 may surround the tubes 1001 at the flanged end 303. Closure of the hemostat 1801 may cause the locking clamp 1803 to compress the tubes 1001 at this location, thus retaining their bowed positions.

FIG. 19 illustrates the handle 1103 being cut from the tubes 1001 by a cutting tool 1901. A cutting blade of the cutting tool 1901 may be positioned just beyond the distal end of the locking clamp 1803 and pressed against the tubes 1001.

FIG. 20 illustrates the tubes 1001 while locked and after having been separated from the handle 1103.

FIG. 21 illustrates an adaptor 2101 being positioned for attachment to the sleeve 301. The adaptor 2101 may be any type of adaptor that may be configured to function with any type afterloader.

FIG. 22 illustrates the adaptor 2101 attached to the sleeve 301. Any type of snap or interlocking device may be used for this purpose.

The adaptor 2101 may include a plurality of adapter tubes 2203. Each of the adapter tubes 2203 may be joined at the juncture between the adaptor 2101 and the sleeve 301 to one of the inner tubes 1401 so as to create a continuous central lumen from the distal ends 2205 of each of the adaptor tubes 2203 to the proximate end 1005 of the inner tubes 1401.

The distal ends 2205 may be coupled to any type of afterloader. The afterloader may be configured to inject one or more strands, each containing one or more radioactive seeds, into the distal end of one or more of the adaptor tubes 2203 and into one or more of the inner tubes 1401. The precise position of each radioactive seed within each of the inner tubes 1401 may be regulated by the afterloader, as well as the dwell time at each position.

The afterloader may be programmed to cause a single radioactive seed within a single strand to be sequentially injected into one or more of the inner tubes 1401 at one or more specified locations for one or more specified dwell times. Any type or combination of types of radiation treatment may be employed.

After completion of the radiation treatment, the adaptor 2101 may be detached from the sleeve 301 and a cap may be placed on the distal end of the sleeve 301 to protect it.

FIG. 23 illustrates a cap 2301 attached to the distal end of the sleeve 301. The cap 2301 may remain attached until the next treatment is administered. At this time, the cap 2301 may be removed and the process described above in connection with FIGS. 21 and 22 may be repeated in the same or in a different way.

After one or more radiation treatments, the tube apparatus that is shown in FIG. 21 may be removed. FIG. 24 illustrates the hemostat 2401 being used to unlock the locking clamp 1803. After the locking clamp 1803 is unlocked, the tubes may naturally tend to go back to their straightened position.

FIG. 25 illustrates the hemostat 2401 being used to straighten the tubes 1001. As shown in FIG. 25, the tubes may not fully straighten on their own. By pulling them distally with the hemostat 2401, they may be completely straightened.

FIG. 26 illustrates the hemostat 2401 being used to grab the tubes 1001 after they have been completely straightened.

FIG. 27 illustrates the straightened tubes 1001 being removed from the sleeve 301 by the hemostat 2401. Thereafter, the sleeve 301 may be removed from the breast.

FIG. 28 illustrates the sleeve 301 being removed from the breast 205. The opening 207 in the breast 205 may then be sutured and allowed to heal.

The components, steps, features, objects, benefits and advantages that have been discussed are merely illustrative. None of them, nor the discussions relating to them, are intended to limit the scope of protection in any way. Numerous other embodiments are also contemplated, including embodiments that have fewer, additional, and/or different components, steps, features, objects, benefits and advantages. The components and steps may also be arranged and ordered differently.

For example, the device and procedures that have been described may be used in conjunction with brachytherapy treatments for tissue other than breast tissue, such as for the brain and/or the prostate. Although a strand with one or more radioactive seeds has thus-far been described as being inserted into the inner tubes 1401, one or more strands containing one or more seeds may in addition or instead be inserted into a lumen in one or more of the outer tubes 1107.

Apparatus may be provided that facilitates bowing of one or more members of the outer tubes 1107 on an individual basis, rather than bowing in unison as has been described.

Different types of devices and apparatuses may be used for the tubes, to control and/or regulate their movement, and/or to feed them with radioactive seeds, then have been described. A radioactive source other than a seed may be used in addition or instead.

The patent applications that have been incorporated by reference in the Cross-Reference to Related Applications section of this application disclose a broad variety of related devices, components, and procedures. One or more of these may be used in conjunction with the devices, components, and/or procedures that are described in this application and/or in lieu of some or all of them.

Nothing that has been stated or illustrated is intended to cause a dedication of any component, step, feature, object, benefit, advantage, or equivalent to the public.

Claims

1. A brachytherapy device comprising a plurality of rods, each configured to move between a straightened position and a bowed position, the plurality of rods configured to collectively form a shaft while each rod is in the straightened position and to collectively form at least one cage while at least some of the rods are in the bowed position, at least some of the rods having lumens that are configured to receive and hold radioactive material, wherein some of the rods are configured to form a first cylinder while in the straightened position and the other rods are configured to form a second cylinder while in the straightened position that surrounds the first cylinder, whereby the plurality of rods are further configured such that at least a substantial portion of each rod in the second cylinder lies between two rods within the first cylinder while in the straightened position.

2. The brachytherapy device of claim 1 further comprising a rotatable mechanism configured to move the second cylinder between the straightened position and the bowed position.

3. A brachytherapy device comprising a plurality of rods, each configured to move between a straightened position and a bowed position, the plurality of rods configured to collectively form a shaft while each rod is in the straightened position and to collectively form at least one cage while at least some of the rods are in the bowed position, at least some of the rods having lumens that are configured to receive and hold radioactive material, wherein each rod has opposing longitudinal flanges, each of which is configured to overlap with a longitudinal flange of a neighboring rod while in the straightened position.

4. The brachytherapy device of claim 3 further comprising a rotatable mechanism configured to move some of the rods between the straightened position and the bowed position.

5. A brachytherapy device comprising:

a first and a second set of rods, at least some of the rods having lumens that are configured to receive and hold radioactive material;
a group expansion mechanism associated with the first set of rods and configure to collectively move the first set of rods in unison, each between a straightened position and a bowed position, the first set of rods configured to collectively form a shaft while each of the first set of rods is in the straightened position and to collectively form a cage while each of the first set of rods is in the bowed position; and
a rod bowing mechanism associated with each of the second set of rods and configured to individually move each of the second set of rods between a straightened and a bowed position, the second set of rods configured to collectively form a shaft while each of the second set of rods is in the straightened position.

6. The brachytherapy device of claim 5 wherein the group expansion mechanism includes a rotatable mechanism configured to move the first set of rods in unison between the straightened position and the bowed position.

7. A brachytherapy device comprising:

a plurality of rods configured to move between a straightened position and a bowed position, the rods configured to collectively form a shaft while each of the rods is in the straightened position, at least some of the rods having lumens configured to receive and hold radioactive material; and
a plurality of actuators, each associate with one of the rods and configured to cause the rod with which it is associated to move from the straightened position to the bowed position in incremental steps, each of the incremental steps being delineated by a ratchet mechanism.
Referenced Cited
U.S. Patent Documents
3224432 December 1965 Billingsley
3807326 April 1974 Rocoplan et al.
3872856 March 1975 Clayton
3927325 December 1975 Hungate et al.
4434789 March 6, 1984 Kumar
4584991 April 29, 1986 Tokita et al.
4763642 August 16, 1988 Horowitz
4815449 March 28, 1989 Horowitz
4976680 December 11, 1990 Hayman et al.
5007437 April 16, 1991 Sterzer
5050930 September 24, 1991 Schuster et al.
5125925 June 30, 1992 Lundahl
5147282 September 15, 1992 Kan
5317616 May 31, 1994 Swerdloff et al.
5336178 August 9, 1994 Kaplan et al.
5345936 September 13, 1994 Pomeranz et al.
5411466 May 2, 1995 Hess
5429582 July 4, 1995 Williams
5431648 July 11, 1995 Lev
5484384 January 16, 1996 Fearnot
5540659 July 30, 1996 Teirstein
5611767 March 18, 1997 Williams
5623940 April 29, 1997 Daikuzono
5643171 July 1, 1997 Bradshaw et al.
5653683 August 5, 1997 D'Andrea
5662580 September 2, 1997 Bradshaw et al.
5678572 October 21, 1997 Shaw et al.
5683345 November 4, 1997 Waksman et al.
5688220 November 18, 1997 Verin et al.
5720717 February 24, 1998 D'Andrea
5730698 March 24, 1998 Fischell et al.
5817104 October 6, 1998 Bilitz et al.
5836868 November 17, 1998 Ressemann et al.
5840008 November 24, 1998 Klein et al.
5851171 December 22, 1998 Gasson
5855546 January 5, 1999 Hastings et al.
5863284 January 26, 1999 Klein
5863285 January 26, 1999 Coletti
5879282 March 9, 1999 Fischell et al.
5904680 May 18, 1999 Kordis et al.
5910101 June 8, 1999 Andrews et al.
5910102 June 8, 1999 Hastings
5913813 June 22, 1999 Williams et al.
5916143 June 29, 1999 Apple et al.
5931774 August 3, 1999 Williams et al.
5938582 August 17, 1999 Ciamacco, Jr. et al.
5968040 October 19, 1999 Swanson et al.
6011995 January 4, 2000 Guglielmi et al.
6013019 January 11, 2000 Fischell et al.
6022308 February 8, 2000 Williams
6030333 February 29, 2000 Sioshansi et al.
6036631 March 14, 2000 McGrath et al.
6050930 April 18, 2000 Teirstein
6059812 May 9, 2000 Clerc et al.
6066083 May 23, 2000 Slater et al.
6074339 June 13, 2000 Gambale et al.
6083148 July 4, 2000 Williams
6149574 November 21, 2000 Trauthen et al.
6152869 November 28, 2000 Park et al.
6196963 March 6, 2001 Williams
6196996 March 6, 2001 Teirstein
6200257 March 13, 2001 Winkler
6213976 April 10, 2001 Trerotola
6216043 April 10, 2001 Swanson et al.
6217503 April 17, 2001 Weinberger et al.
6217585 April 17, 2001 Houser et al.
6238374 May 29, 2001 Winkler
6263236 July 17, 2001 Kasinkas et al.
6267775 July 31, 2001 Clerc et al.
6338709 January 15, 2002 Geoffrion et al.
6391026 May 21, 2002 Hung et al.
6409652 June 25, 2002 Kamdar et al.
6413203 July 2, 2002 Sahatjian
6413204 July 2, 2002 Winkler et al.
6482142 November 19, 2002 Winkler et al.
6537194 March 25, 2003 Winkler
6554760 April 29, 2003 Lamoureux et al.
6589158 July 8, 2003 Winkler
6607476 August 19, 2003 Barnhart
6607477 August 19, 2003 Longton et al.
6607478 August 19, 2003 Williams
6638727 October 28, 2003 Hung et al.
6642010 November 4, 2003 Love et al.
6652548 November 25, 2003 Evans et al.
6659105 December 9, 2003 Burbank et al.
6673006 January 6, 2004 Winkler
6676658 January 13, 2004 Burbank et al.
6685718 February 3, 2004 Wyzgala et al.
6695760 February 24, 2004 Winkler et al.
6712816 March 30, 2004 Hung et al.
6743184 June 1, 2004 Sampson et al.
6749555 June 15, 2004 Winkler et al.
6770058 August 3, 2004 Liprie
6840936 January 11, 2005 Sliwa, Jr. et al.
6855160 February 15, 2005 Gambale et al.
6872183 March 29, 2005 Sampson et al.
6893450 May 17, 2005 Foster
6923754 August 2, 2005 Lubock
6955641 October 18, 2005 Lubock
6976949 December 20, 2005 Winkler et al.
6994688 February 7, 2006 Brauckman et al.
7063670 June 20, 2006 Sampson et al.
20010021826 September 13, 2001 Winkler
20020133151 September 19, 2002 Hung et al.
20020173816 November 21, 2002 Hung
20020193653 December 19, 2002 Winkler
20030022161 January 30, 2003 Love et al.
20030032851 February 13, 2003 Apple et al.
20030039959 February 27, 2003 Love et al.
20030049262 March 13, 2003 Love et al.
20030092957 May 15, 2003 Scott et al.
20030149329 August 7, 2003 O'Foghludha
20030191412 October 9, 2003 Sampson et al.
20040016728 January 29, 2004 Liu et al.
20040023912 February 5, 2004 Hung
20040029202 February 12, 2004 Love et al.
20040054368 March 18, 2004 Truckai et al.
20040091423 May 13, 2004 Hung et al.
20040109823 June 10, 2004 Kaplan
20040116767 June 17, 2004 Lebovic et al.
20040167372 August 26, 2004 Winkler et al.
20040191854 September 30, 2004 Lapen et al.
20040210101 October 21, 2004 Winkler
20040215099 October 28, 2004 Sampson et al.
20040224347 November 11, 2004 Love et al.
20050004471 January 6, 2005 Hogendijk et al.
20050027157 February 3, 2005 Winkler et al.
20050085681 April 21, 2005 Stubbs et al.
20050101823 May 12, 2005 Linares et al.
20050101824 May 12, 2005 Stubbs
20050101825 May 12, 2005 Winkler et al.
20050101860 May 12, 2005 Patrick et al.
20050107653 May 19, 2005 Patrick et al.
20050113629 May 26, 2005 Patrick et al.
20050124843 June 9, 2005 Singh
20050131267 June 16, 2005 Talmadge
20050131268 June 16, 2005 Talmadge
20050131269 June 16, 2005 Talmadge
20050137498 June 23, 2005 Sakal et al.
20050137499 June 23, 2005 Sheets et al.
20050149159 July 7, 2005 Andreas et al.
20050182286 August 18, 2005 Lubock
20050240073 October 27, 2005 Apffelstaedt et al.
20060014997 January 19, 2006 Kindlein et al.
20060020156 January 26, 2006 Shukla
20060047178 March 2, 2006 Winkler et al.
20060063961 March 23, 2006 Drobnik et al.
20060094923 May 4, 2006 Mate
20060100475 May 11, 2006 White et al.
20060116546 June 1, 2006 Eng
20060129128 June 15, 2006 Sampson
20060135956 June 22, 2006 Sampson et al.
20070049786 March 1, 2007 Edmundson
20070106108 May 10, 2007 Hermann et al.
20070142695 June 21, 2007 White et al.
Foreign Patent Documents
898 752 May 1984 BE
2296430 June 2004 CA
2394562 November 2004 CA
195 13 831 February 1996 DE
195 47 579 March 1997 DE
810004 December 1997 EP
8676200 September 1998 EP
0 998 330 May 2000 EP
0 770 258 October 2001 EP
955 071 February 2004 EP
1 426 063 June 2004 EP
1 568 397 August 2005 EP
1 239 920 May 2006 EP
3-30760 February 1991 JP
2006 26443 February 2006 JP
2 089 143 September 1997 RU
2 128 060 March 1999 RU
WO 96/02059 January 1996 WO
WO 98/15315 April 1998 WO
WO 99/02219 January 1999 WO
WO 99/04856 February 1999 WO
WO 99/22812 May 1999 WO
WO 99/24117 May 1999 WO
WO 99/033515 July 1999 WO
WO 99/33515 July 1999 WO
WO 01/43826 June 2001 WO
WO 2007/056714 May 2007 WO
Other references
  • U.S. Appl. No. 60/625,355, filed Nov. 5, 2004, White et al.
  • U.S. Appl. No. 60/735,649, filed Nov. 10, 2005, Hermann et al.
  • Anbai, A. et al. Brachytherapy with Iridium-192 Thin Wire for Head and Neck Carcinoma. Jibi Inkoka, Tokeibu Geka (Otolaryngology—Head and Neck Surgery), 1998, vol. 70, No. 7, pp. 417-421. (In Japanese, Abstract only).
  • Armstrong, J.G. et al. The Use of a Prosthetic Tissue Expander to Displace Bowel from a Brachytherapy Implant Site. International Journal of Radiation Oncology, Biology, Physics, Dec. 1990, vol. 19, No. 6, pp. 1521-1523.
  • Balter, S. Endovascular Brachytherapy: Physics and Technology. Catheterization and Cardiovascular Diagnosis, 1998, vol. 45, No. 3, pp. 292-298.
  • Benitez, P.R. et al. Preliminary Results and Evaluation of MammoSite Balloon Brachytherapy for Partial Breast Irradiation for Pure Ductal Carcinoma in Situ: A Phase II Clinical Study. American Journal of Surgery, 2006, vol. 192, No. 4, pp. 427-433.
  • Diederich, C.J. et al. Direct-Coupled Interstitial Ultrasound Applicators for Simultaneous Thermobrachytherapy: A Feasibility Study. International Journal of Hyperthermia, May-Jun. 1996, vol. 12, No. 3, pp. 401-419.
  • Do, L. et al. LDR Brachytherapy Implants as a Boost in Early Stage Breast Cancer in Women with Cilastic Implants. In Proceedings of the American Brachytherapy Society, 27th Annual Meeting, 2006, vol. 5, No. 2, p. 95. (Abstract only).
  • Fukui, A. et al. Problems of Treatment Planning of Intracavitary Brachytherapy for Advanced Esophageal Cancer. Rinsho Hoshasen (Japanese Journal of Clinical Radiology), 1999, vol. 44, No. 8, pp. 981-984. (In Japanese, Abstract only).
  • Gildenberg, P.L. et al. Fractionated Brachytherapy: Catheter Insertion and Dosimetry. Stereotact. Funct. Neurosurg. 1994, vol. 63, Nos. 1-4, pp. 246-249.
  • Hirschberg, H. et al. An Indwelling Brachytherapy Balloon Catheter: Potential Use as an Intracranial Light Applicator for Photodynamic Therapy. Journal of Neuro-Oncolocy, Aug. 1999, vol. 44, No. 1, pp. 15-21.
  • Inakoshi H. et al. A New Radiotherapy Planning Program Using a New Double-Lumen Ballon Applicator for High-Dose-Rate Intracavitary Irradiation of Esophageal Cancer. Rinsho Hoshasen (Japanese Journal of Clinical Radiology), 1993, vol. 38, No. 5, pp. 565-569. (In Japanese, Abstract only).
  • International Search Report for PCT Application No. PCT/US2007/083672, International Filing Date, Nov. 5, 2007. Search Report mailed May 20, 2008.
  • International Search Report for PCT Application No. PCT/US06/45081, International Filing Date, Nov. 21, 2006, date of mailing Apr. 4, 2007.
  • Jani, S.K. et al. Dose Anisotropy Around an Au-198 Seed Source. Medical Physics, Jul.-Aug. 1989, vol. 16, No. 4, pp. 632-635.
  • Kubo, H.D. et al. Impact of Collimator Leaf Width on Stereotatic Radioosurgery and 3D Conformal Radiotherapy Treatment Plans. International Journal of Radiation Oncology Biology Physics, Jul. 1, 1999, vol. 44, No. 4, pp. 937-945.
  • Kuske, R.R. et al. Wide Volume Brachytherapy Alone for Select Breast Cancers: The Ten Year Experience of the Ochsner Clinic. International Journal of Radiation Oncology Biology Physics, 2000: vol. 48, No. 3; Suppl. 1, p. 2063. (Abstract only).
  • Malgieri, M. Relative Effects of Different Modalities of Brachytherapy on Late Responding Tissues and Tumours. Radiotherapy and Oncology, 1996, vol. 39, No. Sup. 1, p. 88. (Abstract only).
  • Marinello, G. et al. Comparative Dosimetry Between Iridium Wires and Seed Ribbons. International Journal of Radiation Oncology, Biology, Physics, Sep. 1985, vol. 11, No. 9, pp. 1733-1739.
  • Mazeron, J.J. et al. Treatment of Bladder Tumors by Iridium 192 Implantation. The Creteil Technique. Oncology (Netherlands), 1985, vol. 4, No. 2, pp. 111-119.
  • Muller-Runkel R. et al. Brachytherapy Implants with Differently Spaced Ir-192 Seeds: A Dosimetric Study. Radiology, Oct. 1987, vol. 165, No. 1, pp. 271-274.
  • Ogawa, K. et al. Intraluminal Brachytherapy Using a Balloon Applicator for Superficial Esophageal Carcinoma: Importance of Applicator Confirmation by Computed Tomography. Radiation Medicine, 1999, vol. 17, No. 5, pp. 399-401.
  • Pierquin, B. et al. Intracavitary Irradiation of Carcinomas of the Uterus and Cervix: The Cretail Method. International Journal of Radiation Oncology, Biology, Physics, Dec. 1988, vol. 15, No. 6, pp. 1465-1473.
  • Popowski, Y. et al. Intra-arterial 90 Y Brachytherapy: Preliminary Dosimetric Study Using a Specially Modified Angioplasty Balloon. International Journal of Radiation Oncology Biology Physics, Oct. 1995, vol. 33, No. 3, pp. 713-717.
  • Rownd, J. Applicator Design and Dose Distributions. In Medical Physics Monograph, No. 31, pp. 797-804 (Madison, WI: Medical Physics Publishing, 2005).
  • Sealy, R. et al. The Treatment of Cancer of the Uvula and Soft Palate with Interstitial Radioactive Wire Implants. International Journal of Radiation Oncology, Biology, Physics, 1984, vol. 10, No. 10, pp. 1951-1955.
  • Xu, Z. et al. The Investigation of 32 P Wire for Catheter-Based Endovascular Irradiation. Medical Physics, Nov. 1997, vol. 24, No. 11, pp. 1788-1792.
  • Yorozu, A. et al. Curative Radiotherapy with High-Dose-Rate Brachytherapy Boost for Localized Esophageal Carcinoma: Dose-Effect Relationship of Brachytherapy with the Balloon Type Applicator System. Radiotherapy and Oncology, May 1999, vol. 51, No. 2, pp. 133-139.
  • Zavgorodni, S.F. et al. Comparison of Three Simply Radiosurgery Techniques for Treating Elongated Lesions. Physica Medica, Apr.-Jun. 1999, vol. 15, No. 2, pp. 57-62.
Patent History
Patent number: 7862497
Type: Grant
Filed: Nov 5, 2007
Date of Patent: Jan 4, 2011
Patent Publication Number: 20080146862
Assignee: Portola Medical, Inc. (Portola Valley, CA)
Inventors: L. Michael Cutrer (Huntington Beach, CA), Fredrick Wintch (Snohomish, WA), Richard A. Terwilliger (Venice, CA), John Zhang (Lake Forest Park, WA), David Bossi (Simi Valley, CA)
Primary Examiner: Samuel G Gilbert
Attorney: McDermott Will & Emery LLP
Application Number: 11/935,348
Classifications
Current U.S. Class: Radioactive Substance Placed Within Body (e.g., Inhaled, Implanted, Injected, Etc.) (600/3)
International Classification: A61N 5/00 (20060101);